Evidence map›Paper›PMID 19019088›Full record

ArticleImmunology2009

Evidence for a human leucocyte antigen-DM-induced structural change in human leucocyte antigen-DObeta.

Francis Deshaies, Djibril A Diallo, Jean-Simon Fortin, Helen M O'Rourke, Abdul Mohammad Pezeshki, Angélique Bellemare-Pelletier, Nicola Raby, Nathalie Bédard, Alexandre Brunet, Lisa K Denzin and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Mapping the HLA-DO/HLA-DM complex by FRET and mutagenesis.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  4. HLA Immune Function Genes in Autism.Autism research and treatment · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Francis DeshaiesLaboratoire d'Immunologie Moléculaire, Département de Microbiologie et Immunologie, Université de Montréal, Montréal, QC, Canada.
Djibril A Diallo
Jean-Simon Fortin
Helen M O'Rourke
Abdul Mohammad Pezeshki
Angélique Bellemare-Pelletier
Nicola Raby
Nathalie Bédard
Alexandre Brunet
Lisa K Denzin
Jacques Thibodeau
Université de Montréal · CACornell University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
H2-O Mediated Antigen Focusing Modulates B Cell ImmunityR01AI061484 · NIAID · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI DENZIN, LISA K. · 2005 to 2009
$2.1M
NCI NIH HHS P30 CA008748NIAID NIH HHS R01 AI061484
6 · The paper itself

Abstract

Human leucocyte antigen (HLA)-DO is a non-classical major histocompatibility complex class II molecule which modulates the function of HLA-DM and the loading of antigenic peptides on molecules such as HLA-DR. The bulk of HLA-DO associates with HLA-DM and this interaction is critical for HLA-DO egress from the endoplasmic reticulum. HLA-DM assists the early steps of HLA-DO maturation presumably through the stabilization of the interactions between the N-terminal regions of the alpha and beta chains. To evaluate a possible role for HLA-DM in influencing the conformation of HLA-DO, we made use of a monoclonal antibody, Mags.DO5, that was raised against HLA-DO/DM complexes. Using transfected cells expressing mismatched heterodimers between HLA-DR and -DO chains, we found that the epitope for Mags.DO5 is located on the DObeta chain and that Mags.DO5 reactivity was increased upon cotransfection with HLA-DM. Our results suggest that HLA-DM influences the folding of HLA-DO in the endoplasmic reticulum. A mutant HLA-DO showing reduced capacity for endoplasmic reticulum egress was better recognized by Mags.DO5 in the presence of HLA-DM. On the other hand, an HLA-DO mutant capable of endoplasmic reticulum egress on its own was efficiently recognized by Mags.DO5, irrespective of the presence of HLA-DM. Taken together, our results suggest that HLA-DM acts as a private chaperone, directly assisting the folding of HLA-DO to promote egress from the endoplasmic reticulum.

Indexed as

Protein FoldingAntibodies, MonoclonalAntigen PresentationB-LymphocytesEndoplasmic ReticulumEpitopes, B-LymphocyteHeLa CellsHLA-D AntigensHumansTransfectionAntibodies, MonoclonalEpitopes, B-LymphocyteHLA-D AntigensHLA-DM antigensHLA-DO antigens

Identifiers

PMID19019088
PMCPMC2712109
OpenAlexW2047449015

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.